Glucose study in cystic fibrosis related diabetes
Part of Genetic & congenital, Hormones & metabolism, Lungs & breathing clinical trials.
This study looks at how the body handles sugar in people with cystic fibrosis related diabetes. Researchers want to learn more about glucose metabolism to improve care for people with CFRD.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 to 75 years old
- You have cystic fibrosis related diabetes (CFRD)
- You are on insulin therapy, preferably using an insulin pump
- You are not taking corticosteroids, benzodiazepines, opiates, barbiturates, or blood thinners
- You are not pregnant and do not have severe anemia or active liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether changing eating habits—especially added sugar intake—affects health in adults with cystic fibrosis. It may help by testing a diet approach aimed at better outcomes related to metabolism and overall health.
This study looks at how long-term diabetes affects people with cystic fibrosis. It helps researchers understand complications and improve care.
This trial studies whether a low glycemic load (a specific way of choosing carbohydrates) improves blood sugar control and body composition in adults with cystic fibrosis–related diabetes. It may help reduce blood sugar problems and support healthier weight and body measurements.
This study tests if a continuous glucose monitor (CGM) along with a standard glucose drink test can better detect diabetes in people with cystic fibrosis. It is for adults who do not yet have diabetes and are generally healthy.
This study looks at genetic (inherited DNA) factors that may influence who develops diabetes related to cystic fibrosis. Your results could help doctors better predict risk and improve care for cystic fibrosis and related diabetes.
This study tests a drug called dorzagliatin to see if it can help control blood sugar in adults with cystic fibrosis who have pancreatic insufficiency and abnormal glucose tolerance.
Hear when a new Cystic Fibrosis-related Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.